Incomplete Comprehensive Care Planning and Resident Participation
Summary
The facility staff failed to include Resident #50 and/or the resident representative in reviews and/or revisions of the comprehensive person-centered care plan. Resident #50 had diagnoses including depression, obstructive and reflux uropathy, COPD, cardiomegaly, tachycardia, metabolic encephalopathy, weakness, and chronic respiratory failure with hypoxia. The resident’s most recent MDS showed a BIMS score of 15 out of 15, indicating cognitive intactness, and during interview the resident could not recall being invited to care plan meetings. The clinical record did not show evidence that the resident and/or representative had been invited to participate in care plan reviews, and social work staff stated the last documented invitation was in May 2025. The facility also failed to develop and implement a care plan for self-administration of medications for Resident #116. The resident’s record included diagnoses related to respiratory conditions and a physician order allowing Flonase and Chloroseptic to be kept at bedside. The resident’s MDS showed a BIMS score of 15 out of 15, indicating cognitive intactness. The comprehensive care plan did not contain a self-administration of medications focus, and the resident stated that Flonase and Chloroseptic were kept in the top drawer of the nightstand. For Resident #11, the facility failed to develop a comprehensive care plan for PTSD. The resident’s diagnoses included PTSD, anxiety disorder, and depression, and the quarterly MDS showed a BIMS score of 14, indicating cognitive intactness. Review of the comprehensive care plan showed no focus area for PTSD. For Resident #32, the facility failed to develop a comprehensive care plan for self-administration of medications. The resident had diagnoses including acute and chronic respiratory failure, chronic diastolic CHF, and diabetes, and the quarterly MDS showed a BIMS score of 12, indicating moderate impairment in cognitive skills for daily decision making. During observation, a bottle of Systane eye drops was seen on the over-bed table, and the record included an order allowing the eye drops to be kept at bedside, but there was no evidence the resident had been assessed for self-administration or that this had been included in the comprehensive care plan.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release August 26, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.